April 23, 2020 | 11: 12 pm
Preliminary outcomes of a research study on hydroxychloroquine in New York revealed that the anti-malaria drug had no effect on critically ill coronavirus clients, Gov. Andrew Cuomo stated Thursday.
The study, sponsored by the Department of Health, looked at about 600 clients at 22 medical facilities in the greater New York City area.
” I think from the evaluation that I heard generally it was not seen as a favorable, not seen as a negative,” Cuomo stated during a CNN city center.
Some seriously ill COVID-19 patients in the state began to be treated with the drug, at times in mix with the antibiotic Zithromax, or azithromycin, earlier this month.
President Trump has promoted hydroxychloroquine as a possible life-saver, although there is no extensive clinical proof to date showing it assists battle COVID-19
Those who took the medication, with or without the antibiotic, weren’t anymore likely to endure than those who didn’t, the lead scientist on the New York research study told CNN.
” We don’t see a statistically considerable distinction in between patients who took the drugs and those who did not,” said David Holtgrave, dean of the University at Albany School of Public Health.
The drug also proved to be no much better than basic care in a smaller sized study of 300 male clients at Veterans Health Administration medical centers across the nation.
